Adorini L - Search Results

1

Capacity of intact proteins to bind to MHC class II molecules.

Sette A, Adorini L, Colon SM, Buus S, Grey HM. Sette A, et al. Among authors: adorini l. J Immunol. 1989 Aug 15;143(4):1265-7. J Immunol. 1989. PMID: 2787361

2

Structural requirements for the interaction between peptide antigens and I-Ed molecules.

Sette A, Adorini L, Appella E, Colón SM, Miles C, Tanaka S, Ehrhardt C, Doria G, Nagy ZA, Buus S, et al. Sette A, et al. Among authors: adorini l. J Immunol. 1989 Nov 15;143(10):3289-94. J Immunol. 1989. PMID: 2809202

3

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Ishioka GY, Adorini L, Guery JC, Gaeta FC, LaFond R, Alexander J, Powell MF, Sette A, Grey HM. Ishioka GY, et al. Among authors: adorini l. J Immunol. 1994 May 1;152(9):4310-9. J Immunol. 1994. PMID: 8157954

4

MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides.

Sette A, Sidney J, Gaeta FC, Appella E, Colón SM, del Guercio MF, Guéry JC, Adorini L. Sette A, et al. Among authors: adorini l. Int Immunol. 1993 Jun;5(6):631-8. doi: 10.1093/intimm/5.6.631. Int Immunol. 1993. PMID: 8347557

5

Structural requirements for the interaction between class II MHC molecules and peptide antigens.

Sette A, Buus S, Appella E, Adorini L, Grey HM. Sette A, et al. Among authors: adorini l. Immunol Res. 1990;9(1):2-7. doi: 10.1007/BF02918474. Immunol Res. 1990. PMID: 2406349 Review.

6

Interaction of an immunodominant epitope with Ia molecules in T-cell activation.

Adorini L, Sette A, Buus S, Grey HM, Darsley M, Lehmann PV, Doria G, Nagy ZA, Appella E. Adorini L, et al. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5181-5. doi: 10.1073/pnas.85.14.5181. Proc Natl Acad Sci U S A. 1988. PMID: 2455895 Free PMC article.

7

Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.

Guéry JC, Sette A, Appella E, Adorini L. Guéry JC, et al. Among authors: adorini l. J Immunol. 1995 Jan 15;154(2):545-54. J Immunol. 1995. PMID: 7814867

8

MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression?

Ruppert J, Franco A, Alexander J, Snoke K, Ishioka GY, Page DM, Hedrick SM, Adorini L, Grey HM, Sette A. Ruppert J, et al. Among authors: adorini l. Chem Immunol. 1995;60:61-78. Chem Immunol. 1995. PMID: 7857529 Review. No abstract available.

9

Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.

Leighton J, Sette A, Sidney J, Appella E, Ehrhardt C, Fuchs S, Adorini L. Leighton J, et al. Among authors: adorini l. J Immunol. 1991 Jul 1;147(1):198-204. J Immunol. 1991. PMID: 1711074

10

Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Guéry JC, Sette A, Leighton J, Dragomir A, Adorini L. Guéry JC, et al. Among authors: adorini l. J Exp Med. 1992 May 1;175(5):1345-52. doi: 10.1084/jem.175.5.1345. J Exp Med. 1992. PMID: 1569402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters